Skip to Content
Merck

83160

L-Pyroglutamic acid

≥99.0% (T), for peptide synthesis

Synonym(s):

(S)-(−)-2-Pyrrolidone-5-carboxylic acid, (S)-5-Oxo-2-pyrrolidinecarboxylic acid

Sign In to View Organizational & Contract Pricing.

Select a Size

All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C5H7NO3
CAS Number:
98-79-3
Molecular Weight:
129.11
NACRES:
NA.22
PubChem Substance ID:
57652948
UNSPSC Code:
12352209
EC Number:
202-700-3
MDL number:
MFCD00005272
Beilstein/REAXYS Number:
82132

Product Name

L-Pyroglutamic acid, ≥99.0% (T)

InChI key

ODHCTXKNWHHXJC-VKHMYHEASA-N

InChI

1S/C5H7NO3/c7-4-2-1-3(6-4)5(8)9/h3H,1-2H2,(H,6,7)(H,8,9)/t3-/m0/s1

SMILES string

OC(=O)[C@@H]1CCC(=O)N1

assay

≥99.0% (T)

form

solid

optical activity

[α]20/D −10.5±1°, c = 5% in H2O

optical purity

enantiomeric ratio: ≥99:1 (GC)

reaction suitability

reaction type: solution phase peptide synthesis

ign. residue

≤0.05%

mp

155-162 °C
160-163 °C (lit.)

application(s)

peptide synthesis

Quality Level

200

Looking for similar products? Visit Product Comparison Guide

Related Categories

Application

L-Pyroglutamic acid is used in the synthesis of:
  • Nonproteinogenic amino acids such as (3S,4R)-3,4-dimethyl-L-pyroglutamic acid and (3S,4R)-3,4-dimethyl-L-glutamine.
  • Chiral N-heterocyclic carbenes (NHCs) as catalysts for the asymmetric dimerization of alkylarylketenes to give the corresponding α-quaternary β-alkylidenyl-β-lactones.

It is also used in the total synthesis of (−)-stemoamide and celogentin C.

pictograms

Corrosion
GHS05

signalword

Danger

hcodes

H318,H412

Hazard Classifications

Aquatic Chronic 3 - Eye Dam. 1

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
BCCL6412
BCCJ8845
BCCG8513
BCCF4459
BCCD8715

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Total Syntheses of (?)-and (−)-Stemoamide
Jacobi PA and Lee K
Journal of the American Chemical Society, 122(18), 4295-4303 (2000)
Asymmetric Dimerization of Disubstituted Ketenes Catalyzed by N-Heterocyclic Carbenes
Lv H and Zhang et al.
advanced synthesis and catalysis, 350(17), 2715-2718 (2008)
Total Synthesis of Celogentin C by Stereoselective C-H Activation
Feng Y and Chen G
Angewandte Chemie (International ed. in English), 122(5), 970-973 (2010)
Synthesis and analysis of the sterically constrained L-glutamine analogues (3S, 4R)-3, 4-dimethyl-L-glutamine and (3S, 4R)-3, 4-dimethyl-L-pyroglutamic acid
Acevedo CM et al.
Tetrahedron, 57(30), 6353-6359 (2001)
M H Creer et al.
Clinical chemistry, 35(4), 684-686 (1989-04-01)
Pyroglutamic acidemia, a rare metabolic disorder, usually appears in infancy. It is characterized by retardation, ataxia, hemolytic anemia, and chronic acidosis and is caused by a marked deficiency of glutathione synthetase (EC 6.3.2.3) activity. This disease is inherited as an
View All Related Papers

Protocols

HPLC Analysis of Organic Acids in Wine/Beer on TSKgel®

Science Slam panel: Leading gene therapy developers discuss commercialization challenges and the importance of robust process development plans.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service